Waldencast (WALDW) Stock Price, News & Analysis

Company Overview

Waldencast plc operates in the beauty and wellness industry. It engages in developing, acquiring, accelerating, and scaling various brands. The company provides cosmetic, over-the-counter, and prescription products under the Obagi Medical, Obagi Clinical, and Obagi Professional brands; and a Skintrinsiq device for use in facial treatments that is used by physicians' offices, spas, and aestheticians. It also offers clean makeup products under the Milk Makeup brand. The company sells its products to dermatologists, plastic surgeons, and other physicians who focuses on aesthetic and therapeutic skincare, including physicians on site at medical spas, through its direct sales force, as well as through distribution partners. Waldencast plc was incorporated in 2020 and is headquartered in White Plains, New York.

Key Stats

• Today's Range: $0.04 to $0.04
• 50-Day Range: $0.04 to $0.10
• 52-Week Range: $0.04 to $0.43
• Volume: 181 shs
• Average Volume: 34,436 shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

WALDW Stock Analysis - Frequently Asked Questions

How have WALDW shares performed this year?

Waldencast's stock was trading at $0.17 on January 1st, 2025. Since then, WALDW stock has decreased by 76.2% and is now trading at $0.0405.

Who are Waldencast's major shareholders?

Top institutional shareholders of Waldencast include Highbridge Capital Management LLC and LMR Partners LLP.

How do I buy shares of Waldencast?

Shares of WALDW stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Computer and Technology
• Industry: Software - Application
• Sub-Industry: N/A
• Current Symbol: NASDAQ:WALDW
• CIK: 1840199
• Web: www.waldencast.com
• Phone: 917 546 6828
• Fax: N/A
• Employees: 284
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: $273.87 million
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A